Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021

SELL
$7.82 - $13.8 $308,890 - $545,100
-39,500 Closed
0 $0
Q4 2020

Feb 03, 2021

BUY
$13.03 - $17.09 $69,059 - $90,577
5,300 Added 15.5%
39,500 $638,000
Q3 2020

Nov 16, 2020

BUY
$12.67 - $23.19 $306,614 - $561,198
24,200 Added 242.0%
34,200 $478,000
Q1 2020

May 06, 2020

BUY
$11.4 - $27.28 $114,000 - $272,800
10,000 New
10,000 $165,000

Others Institutions Holding BCEL

About Atreca, Inc.


  • Ticker BCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,876,000
  • Description
  • Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...
More about BCEL
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.